New Global Survey — Open to kidney cancer patients of all stages. We welcome all Canadian patients to participate!
Since 2006, a number of new medications have become available for kidney cancer. In most situations, patients have a choice between medications and make the choice that is best for them as an individual in consultation with their oncologist.
Kidney Cancer Canada is participating in a global study to determine how patients take medication side effects into consideration when making treatment choices. Questions are designed for patients to consider hypothetical medications with different types of side effects for comparison.
If you are a kidney cancer patient, we invite you to participate in this online survey. The survey takes about 20 minutes to complete and will be open until October 20, 2014.
Please note: Kidney Cancer Canada has received a small grant from Pfizer Inc. in the U.S. for our assistance in customizing this survey for the Canadian context. For your participation in the study, Kidney Cancer Canada will receive a $20 donation for each respondent. All responses will be confidential. There is no obligation to participate. We look forward to sharing the results with you and comparing those results with other countries also participating in the study.
To participate, please click here and select either Canadian English or Canadian French.
If you have any questions about this new survey, please feel free to contact us at: email@example.com
p.s. And for those who have not yet had the chance to tell us what you think kidney cancer research priorities should be, that 10-minute survey for patients and caregivers is still open and looking for your input. Please see blog post immediately below…
Social Media Disclaimer:
“Please note that the privacy and confidentiality of content (text or pictures) shared on social media platforms is not guaranteed. Content may be forged, forwarded, kept indefinitely, or seen by others using the internet whether you share publicly to everyone or privately to specific people. Do not use social media to discuss information you think is sensitive. While you may share this information with a select group of people, someone in your networks may share it more widely without your consent.”